TABLE 2.

Distribution of combined hematology tests among patients with COVID-19 based on severity, sex, and mortality.

Ratio	Median (IQR)	Median (IQR)	p-value*
Severity	Severe n = 635	Non-Severe n = 2645
Neutrophil-to-lymphocyte ratio (NLR)	2.95 (3.65)	2.38 (2.80)	<0.001
Monocyte-to-lymphocyte ratio (MLR)	0.41 (0.31)	0.27 (0.20)	<0.001
Platelet-to-lymphocyte ratio (PLR)	106.9 (102.8)	97.4 (80.6)	0.001
Mean platelet volume/platelet count ratio (MPR)	0.034 (0.018)	0.031 (0.015)	<0.001
Sex	Women n = 1637	Men n = 1643
Neutrophil-to-lymphocyte ratio (NLR)	2.35 (2.48)	2.693 (3.57)	<0.001
Monocyte-to-lymphocyte ratio (MLR)	0.25 (0.16)	0.301 (0.25)	<0.001
Platelet-to-lymphocyte ratio (PLR)	98.99 (75.84)	100.01 (94.02)	0.780
Mean platelet volume/platelet count ratio (MPR)	0.030 (0.014)	0.033 (0.014)	<0.001
Death	Yes n = 103	No n = 3177
Neutrophil-to-lymphocyte ratio (NLR)	9.00 (10.33)	2.44 (2.79)	<0.001
Monocyte-to-lymphocyte ratio (MLR)	0.55 (0.66)	0.27 (0.20)	<0.001
Platelet-to-lymphocyte ratio (PLR)	211.2 (27.3)	98.02 (80.4)	<0.001
Mean platelet volume/platelet count ratio (MPR)	0.040 (0.02)	0.031 (0.01)	<0.001

*Wilcoxon rank-sum test.